Development and preliminary validation of a virtual reality memory test for assessing visuospatial memory.

Alzheimer’s disease head mounted display spatial memory spatial navigation virtual reality

Journal

Frontiers in aging neuroscience
ISSN: 1663-4365
Titre abrégé: Front Aging Neurosci
Pays: Switzerland
ID NLM: 101525824

Informations de publication

Date de publication:
2023
Historique:
received: 07 06 2023
accepted: 06 11 2023
medline: 11 12 2023
pubmed: 11 12 2023
entrez: 11 12 2023
Statut: epublish

Résumé

Visuospatial memory impairment is a common symptom of Alzheimer's disease; however, conventional visuospatial memory tests are insufficient to fully reflect visuospatial memory impairment in daily life. To address patients' difficulties in locating and recalling misplaced objects, we introduced a novel visuospatial memory test, the Hidden Objects Test (HOT), conducted in a virtual environment. We categorized HOT scores into prospective memory, item free-recall, place free-recall, item recognition, and place-item matching scores. To validate the VR memory test, we compared HOT scores among individuals with Alzheimer's disease (AD), amnestic mild cognitive impairment (aMCI), and normal controls (NC), and also compared these scores with those of conventional neuropsychological tests. We tracked the participants' movement paths in the virtual environment and assessed basic features, such as total distance, duration, and speed. Additionally, we performed walking trajectory pattern mining such as outlier and stay-point detection. We designed and implemented the HOT to simulate a house's living room and assess participants' ability to locate hidden objects. Our preliminary results showed that the total HOT score differed among 17 patients with AD, 14 with aMCI, and 15 NC ( The HOT simulating real life showed potential as an ecologically valid test for assessing visuospatial memory function in daily life. Walking trajectory analysis suggested that patients with AD and aMCI wandered rather than going straight toward the hidden objects.

Sections du résumé

Background UNASSIGNED
Visuospatial memory impairment is a common symptom of Alzheimer's disease; however, conventional visuospatial memory tests are insufficient to fully reflect visuospatial memory impairment in daily life.
Methods UNASSIGNED
To address patients' difficulties in locating and recalling misplaced objects, we introduced a novel visuospatial memory test, the Hidden Objects Test (HOT), conducted in a virtual environment. We categorized HOT scores into prospective memory, item free-recall, place free-recall, item recognition, and place-item matching scores. To validate the VR memory test, we compared HOT scores among individuals with Alzheimer's disease (AD), amnestic mild cognitive impairment (aMCI), and normal controls (NC), and also compared these scores with those of conventional neuropsychological tests. We tracked the participants' movement paths in the virtual environment and assessed basic features, such as total distance, duration, and speed. Additionally, we performed walking trajectory pattern mining such as outlier and stay-point detection.
Results UNASSIGNED
We designed and implemented the HOT to simulate a house's living room and assess participants' ability to locate hidden objects. Our preliminary results showed that the total HOT score differed among 17 patients with AD, 14 with aMCI, and 15 NC (
Conclusion UNASSIGNED
The HOT simulating real life showed potential as an ecologically valid test for assessing visuospatial memory function in daily life. Walking trajectory analysis suggested that patients with AD and aMCI wandered rather than going straight toward the hidden objects.

Identifiants

pubmed: 38076533
doi: 10.3389/fnagi.2023.1236084
pmc: PMC10701378
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1236084

Informations de copyright

Copyright © 2023 Kim, Choi, Chin, Lee, Choi and Na.

Déclaration de conflit d'intérêts

JDC is employed by Seers Technology Company Ltd. (Seongnam-si, Republic of Korea). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Neuropsychiatry Neuropsychol Behav Neurol. 1999 Apr;12(2):95-101
pubmed: 10223256
Brain. 2010 Sep;133(9):2702-13
pubmed: 20624814
J Med Internet Res. 2022 Jan 26;24(1):e27641
pubmed: 35080501
J Med Internet Res. 2019 Aug 01;21(8):e14821
pubmed: 31373274
Alzheimers Res Ther. 2013 Nov 21;5(6):58
pubmed: 24257331
Transl Psychiatry. 2020 Jul 1;10(1):211
pubmed: 32612118
Bioinformatics. 1998;14(9):755-63
pubmed: 9918945
JAMA Neurol. 2015 Mar;72(3):287-94
pubmed: 25622185
Neurobiol Aging. 2018 Apr;64:107-115
pubmed: 29358117
J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
Cogn Neurosci. 2013;4(3-4):171-80
pubmed: 24251605
Nat Rev Neurol. 2018 Aug;14(8):496-506
pubmed: 29980763
Lancet Neurol. 2011 May;10(5):424-35
pubmed: 21481640
Front Aging Neurosci. 2018 Oct 01;10:282
pubmed: 30327596
Front Aging Neurosci. 2015 May 20;7:88
pubmed: 26042034
Front Aging Neurosci. 2019 Oct 18;11:280
pubmed: 31680934
Front Hum Neurosci. 2021 Feb 05;15:628818
pubmed: 33613216
Arch Neurol Psychiatry. 1945 Sep;54:212-6
pubmed: 21004267
J Prev Alzheimers Dis. 2018;5(4):216-234
pubmed: 30298179
Dement Neurocogn Disord. 2019 Sep;18(3):77-95
pubmed: 31681443
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
J Neurosci Methods. 2020 Feb 15;332:108547
pubmed: 31830545
Sci Rep. 2018 Jul 10;8(1):10421
pubmed: 29991732
Neuropsychologia. 2012 Apr;50(5):592-602
pubmed: 22261400
Neuropsychologia. 2011 Feb;49(3):518-27
pubmed: 21185847
Neuropsychologia. 2015 Jul;73:169-75
pubmed: 26002757

Auteurs

Ko Woon Kim (KW)

Department of Neurology, Jeonbuk National University Medical School and Hospital, Jeonju, Republic of Korea.
Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea.

Jong Doo Choi (JD)

Technology Development, Seers Technology Company Ltd., Seongnam-si, Republic of Korea.

Juhee Chin (J)

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Byung Hwa Lee (BH)

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Jee Hyun Choi (JH)

Center for Neuroscience, Korea Institute of Science and Technology, Seoul, Republic of Korea.

Duk L Na (DL)

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Cell and Gene Therapy Institute(CGTI), Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea.
Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.

Classifications MeSH